Merck Hits New 52-Week High at $135.67 Amid Pharmaceutical Sector Growth

Merck & Co., Inc. has reached a new milestone in its growth journey by hitting a 52-week high of USD 135.67 on August 13, 2026.

This achievement underscores the company's strong market position and solid fundamentals, which have contributed to its success in the Pharmaceuticals & Biotechnology sector.

With a market capitalization of USD 421.597 million, Merck is categorized as a large-cap entity.

The company's key financial metrics also highlight its effectiveness and profitability, including a return on equity (ROE) of 42.82% and a debt-to-equity ratio of 0.66.